nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.04.2010 | Editorial Commentary

Amino acid PET and clinical management of glioma patients

verfasst von: Karl Herholz

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Excerpt

In this issue, Yamane et al. [11] report a remarkable finding: Use of ¹¹C-methionine PET (MET PET) changed clinical management in 50% of their patients with brain tumours. One wonders whether this imaging technique is so much better than standard diagnostic procedures and whether usual clinical decisions without ¹¹C-methionine PET are so bad. …

Cha S. Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 2006;27:475–87.PubMed

Claus EB, Black PM. Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001. Cancer 2006;106:1358–63.CrossRefPubMed

Jacobs A. Amino acid uptake in ischemically compromised brain tissue. Stroke 1995;26:1859–66.PubMed

Johannesen TB, Langmark F, Lote K. Progress in long-term survival in adult patients with supratentorial low-grade gliomas: a population-based study of 993 patients in whom tumors were diagnosed between 1970 and 1993. J Neurosurg 2003;99:854–62.CrossRefPubMed

Pirotte B, Goldman S, Dewitte O, Massager N, Wikler D, Lefranc F, et al. Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures. J Neurosurg 2006;104:238–53.CrossRefPubMed

Pöpperl G, Götz C, Rachinger W, Gildehaus FJ, Tonn JC, Tatsch K. Value of O-(2-[18F]fluoroethyl)-L-tyrosine PET for the diagnosis of recurrent glioma. Eur J Nucl Med Mol Imaging 2004;31:1464–70.CrossRefPubMed

Taphoorn MJB, Klein M. Cognitive deficits in adult patients with brain tumours. Lancet Neurol 2004;3:159–68.CrossRefPubMed

Tsuyuguchi N, Sunada I, Ohata K, Takami T, Nishio A, Hara M, et al. Evaluation of treatment effects in brain abscess with positron emission tomography: comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine. Ann Nucl Med 2003;17:47–51.CrossRefPubMed

van den Bent MJ, Hegi ME, Stupp R. Recent developments in the use of chemotherapy in brain tumours. Eur J Cancer 2006;42:582–8.CrossRefPubMed

10.

Weckesser M, Langen KJ, Rickert CH, Kloska S, Straeter R, Hamacher K, et al. O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours. Eur J Nucl Med Mol Imaging 2005;32:422–9.CrossRefPubMed

11.

Yamane T, Sakamoto S, Senda M. Clinical impact of 11C-methionine PET on expected management of patients with brain neoplasm. Eur J Nucl Med Mol Imaging 2010. doi:10.1007/s00259-009-1302-y.PubMed

Titel: Amino acid PET and clinical management of glioma patients
verfasst von: Karl Herholz
Publikationsdatum: 01.04.2010
Verlag: Springer-Verlag
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 4/2010
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-009-1366-8

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2010

Darwinian molecular imaging in nuclear cardiology

Ultrafast nuclear myocardial perfusion imaging on a new gamma camera with semiconductor detector technique: first clinical validation

Five months’ follow-up of patients with and without iodine-positive lymph node metastases of thyroid carcinoma as disclosed by 131I-SPECT/CT at the first radioablation

Guidelines for the labelling of leucocytes with 111In-oxine

Clinical impact of 11C-methionine PET on expected management of patients with brain neoplasm

Abnormal response to mental stress in patients with Takotsubo cardiomyopathy detected by gated single photon emission computed tomography